Literature DB >> 8047819

The microbiology and epidemiology of Helicobacter pylori infection.

A Lee1.   

Abstract

Helicobacter pylori is part of a genus of specialized bacteria that have adapted to the ecological niche provided by gastric mucus. H. pylori has exploited the human niche, while further species of Helicobacter have inhabited the gastric mucosa of other animals. The preferred habitat of H. pylori is the gastric antrum. In humans with normal gastric function, the organism is mainly restricted to the antral surface, where a number of specialized traits allow it to flourish, while causing minimal harm to its host. These include a characteristic motility that allows it to swim rapidly through viscous mucus, and the ability to manufacture large amounts of the enzyme urease. This enzyme breaks down endogenous urea to form ammonia, which protects the bacterium from gastric acidity. Specific adhesions bind a number of the bacteria to the gastric surface, some swim freely in the mucus, and others possibly endocytose into the epithelial cells. It is probably these inaccessible colonization sites that make the organism so difficult to eradicate. In some patients, the normally harmless balance between host and bacterium is disturbed, resulting in peptic ulceration. Modifications to the mucus or epithelial surface in the proximal duodenum, towards the gastric phenotype, make the tissue more susceptible to H. pylori infection of the duodenum by spread of organisms from the antrum. Gastric acid output becomes further increased and the duodenal mucosa is rendered more susceptible to acid attack, leading to peptic ulceration. In other situations, the level of inflammation is enhanced and immunopathology results, followed in the longer term in some cases by atrophy and gastric cancer.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8047819

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  15 in total

1.  Alterations in gastric mucin synthesis by Helicobacter pylori.

Authors:  James C Byrd; Robert S Bresalier
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

2.  Development of a selective medium for isolation of Helicobacter pylori from cattle and beef samples.

Authors:  T H Stevenson; L M Lucia; G R Acuff
Journal:  Appl Environ Microbiol       Date:  2000-02       Impact factor: 4.792

3.  Uptake of Helicobacter pylori outer membrane vesicles by gastric epithelial cells.

Authors:  Heather Parker; Kenny Chitcholtan; Mark B Hampton; Jacqueline I Keenan
Journal:  Infect Immun       Date:  2010-09-27       Impact factor: 3.441

4.  Involvement of the HP0165-HP0166 two-component system in expression of some acidic-pH-upregulated genes of Helicobacter pylori.

Authors:  Yi Wen; Jing Feng; David R Scott; Elizabeth A Marcus; George Sachs
Journal:  J Bacteriol       Date:  2006-03       Impact factor: 3.490

5.  Unidentified intralesional and intracellular coccoid microorganism discovered in the young man with a diffuse erosive gastroduodenitis and multiple superficial ulcerations.

Authors:  Takayuki Okada; Graham Adkins
Journal:  BMJ Case Rep       Date:  2014-02-04

6.  Evidence for specific secretion rather than autolysis in the release of some Helicobacter pylori proteins.

Authors:  A Vanet; A Labigne
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

Review 7.  Clarithromycin and omeprazole as helicobacter pylori eradication therapy in patients with H. pylori-associated gastric disorders.

Authors:  A Markham; D McTavish
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

8.  The antibody titers to Helicobacter pylori in 7 - 12 year old iron deficiency anemic children, in Ilam.

Authors:  Morteza Hoseinzadeh; Afra Khosravi; Koroush Sayemiri; Mohammad Hossein Rasoli; Alireza Mohaveri
Journal:  J Res Med Sci       Date:  2010-11       Impact factor: 1.852

Review 9.  Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders.

Authors:  M I Wilde; D McTavish
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

10.  Toward the development of a stable, freeze-dried formulation of Helicobacter pylori killed whole cell vaccine adjuvanted with a novel mutant of Escherichia coli heat-labile toxin.

Authors:  Nancy A Summerton; Richard W Welch; Laureano Bondoc; Huei-Hsiung Yang; Brett Pleune; Naryaswamy Ramachandran; Andrea M Harris; Desiree Bland; W James Jackson; Sukjoon Park; John D Clements; Gary S Nabors
Journal:  Vaccine       Date:  2009-11-06       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.